How Immunohistochemistry Supports Personalized Medicine
Technological Innovations in Immunohistochemistry
The Immunohistochemistry Market is in a state of rapid evolution, driven by a wave of technological innovations that are enhancing the precision, efficiency, and scalability of diagnostic and research applications. One of the most significant advancements is the rise of automation in immunohistochemistry (IHC) workflows. Automated staining platforms, such as those offered by leading market players like Roche and Danaher Corporation, are replacing traditional manual methods, which are labor-intensive and prone to human error. These automated systems ensure standardization and reproducibility, which are critical for achieving consistent and reliable results, particularly in high-volume clinical laboratories. This shift is also paving the way for digital pathology, where stained slides are scanned and converted into digital images, allowing for remote viewing, collaborative diagnostics, and the application of artificial intelligence (AI) for image analysis. AI algorithms are being developed to assist pathologists in quantifying staining intensity and identifying subtle patterns,…

